ABSTRACT When normal human peripheral lymphocytes are treated with mitogen and grown in the presence of [3H]putrescine or [terminal methylenes-3H]spermidine, label is incorporated predominantly into one cellular protein. The radioactive constituent of this protein was identified as the unusual amino acid hypusine [Nt-4-amino-2-hydi-oxybutyl)lysine]. This was accomplished by isolation of the component from proteolytic digests or acid hydrolysates and comparison with authentic hypusine by chromatography, conversion to the 2,4-dintitrophenyl derivative, and oxidative degradation. The observed relationships among intracellular levels of labeled putrescine, polyamines, and protein bound hypusine after growth of cells with the various labeled amines and with or without an inhibitor of polyamine biosynthesis supply evidence that spermidine is the immediate amine precursor of hypusine and that the 4-amino-2-hydroxybutyl portion ofhypusine derives from the butylamine moiety of spermidine.
While studying the role of polyamines as physiological substrates for transglutaminases, we observed an unidentified radiolabeled material in proteolytic digests ofthe protein fraction from normal human peripheral lymphocytes that had been treated with mitogen in the presence of [3H] putrescine. This labeled basic component of lymphocyte protein was initially thought to be N'-(y-glutamyl.)spermidine because it chromatographed in a position close to that ofthis y-glutamylpolyamine in the ion exchange system used. It was subsequently recognized and reported (1) as an unknown componentof lymphocyte protein. This conclusion was based on its observed stability to acid hydrolysis. We now report that this compound, which is the major labeled component formed in the lymphocyte protein fraction during growth ofthe cells with eitherlabeled putrescine or labeled spermidine, is the unusual amino acid hypusine. The present report provides evidence for the identity of this amino acid and for the direct precursor role of spermidine in its biosynthesis. In addition, it is shown that hypusine occurs predominantly in one protein of lymphocytes.
Hypusine was discovered by Nakajima and coworkers (2) , who isolated the free amino acid from homogenates of bovine brain and determined its structure as N8-(4-amino-2-hydroxybutyl)lysine. In addition to its detection in free form in a number of organs of several mammals (3), hypusine was found to be a constituent of animal proteins (4) . Attempts to find any specific protein abundant in this amino acid were, however, without success (4) . EXPERIMENTAL PROCEDURE Materials. [2,3-3H (N)]Putrescine-2HC1, [ terminal, methylenes-3H(N)]spermidine-3HCl, and [3-aminopropyl-3-3H(N)]-spermine-4HCI were purchased from New England Nuclear. Their specific radioactivities were >20 Ci/mmol (1 Ci = 3.7 X 10'°becquerels) and each was used without dilution of specific radioactivity. Methylglyoxalbis(guanylhydrazone)-2HCl'H20 (MGBG) was from Aldrich. Hypusine, isolated by T. Nakajima and his colleagues and provided by them to John W. Daly of the National Institutes of Health, was a gift from him to us. Other materials and reagents have been described (1) .
Methods. Human peripheral lymphocytes from healthy normal donors were purified by a combination of nylon column adsorption and density separation as described (5) and cultured at a density of 106 cells per ml in RPMI 1640 containing glutamine (0.3 mg/ml), penicillin (50 international units/ml), streptomycin (50 international units/ml), 10 mM Hepes, pH 7.4, and 10% autologous plasma. Growth was induced by addition of phytohemagglutinin (Wellcome, Beckenham, England) at 5 ,ug/ml the day after purification. Additions oflabeled amines were made together with the mitogen at 5 ACi/ml except where noted otherwise. Cells were harvested by centrifugation for 10 min at 260 X g at 35°C. The cells were washed twice with ice-cold phosphate-buffered saline (pH 7.4). The cell pellet was suspended in a small volume of phosphate-buffered saline, and an equal volume of 20% trichloroacetic acid was added. Further details of preparation of trichloroacetic acid precipitates and supernatant fractions are given elsewhere (1) . Enzymic digestions oftrichloroacetic acid precipitates were carried out as described (1) . Acid hydrolysis was performed in 6 M HC1 at 106°C for 18 hr in sealed evacuated tubes.
Ion exchange chromatographic separations were conducted by using a Dionex D-400 analyzer with the three-buffer system under conditions described (1) . For measurement of radioactivity and other external analyses, collection of effluent was made directly from the column without mixing with fluorometric reagent.
Radioactivity was measured in Hydrofluor counting fluid (National Diagnostics, Somerville, NJ) by using a liquid scintillation spectrometer. The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 Further evidence for the identity of this component was obtained from oxidation experiments, the results ofwhich are also given in Table 1 . Nakajima and coworkers (2) Fractions were collected every 24 sec. Preparation of the 3H-labeled y-glutamylspermidines was carried out as described (1) Identification of Spermidine as the Precursor of Hypusine. The data shown in Fig. 2 provide evidence that spermidine is the direct precursor of the 4-amino-2-hydroxybutyl portion of lymphocyte hypusine. Examination of the distribution of label in the cellular amine fractions from lymphocytes shows that, after 24 hr, more than half of the label in this fraction from cells grown with [3H] putrescine is in the form of spermidine and spermine (experiment 1). This fraction from cells supplied with labeled spermidine, on the other hand, contains most of the label as spermidine and spermine and very little in the form of putrescine (experiment 3). This observation, together with the fact that both labeled putrescine and labeled spermidine are good exogenous sources of label for hypusine, suggests that spermidine or spermine, rather than putrescine, is the direct precursor of hypusine.
RESULTS

Identification of Hypusine in the Protein
When lymphocytes are grown with [3H]putrescine in the presence of MGBG, a potent inhibitor of the enzyme S-adenosylmethionine decarboxylase (7) , most of the label in the cells is present as putrescine; little label occurs in the polyamines (experiment 2). This is the case because S-adenosylmethionine decarboxylase catalyzes formation of decarboxylated S-adenosylmethionine, which is the source of the propylamine moiety for the biosynthesis of spermidine from putrescine and of spermine from spermidine (for review, see refs. [8] [9] [10] . The cells grown with [3H]putrescine in the presence of MGBG also incorporate very little label into hypusine (experiment 2). In contrast, addition of MGBG with labeled spermidine (experiment 4) does not reduce the labeling of hypusine as compared with that which occurs without the inhibitor (experiment 3). As expected, MGBG does inhibit label from entering spermine. Consequently, most of the labeltin the amine pool of MGBGtreated cells that are supplied labeled spermidine remains as spermidine. The relationships between the labeled spermidine composition of the cellular amine pools and the labeled hypusine content provide strong evidence that hypusine in lymphocyte protein derives directly from cellular spermidine.
The results shown in Fig. 3 supply evidence that only label from the butylamine moiety of the unsymmetrical polyamine, spermidine, enters hypusine during its biosynthesis. When lymphocytes were grown in the presence of spermine that was 3H-labeled in only its propylamine portions, a significant degree of conversion of labeled spermine to spermidine occurred (experiment 3). However, no trace of radioactivity was found in the hypusine fraction from these cells. In parallel experiments with [3H]putrescine, from which spermidine labeled in its butylamine moiety is formed (experiment 1), and with spermidine, in which both the butylamine and the propylamine portions are labeled (Experiment 2), good labeling of hypusine was observed. The simplest explanation for the failure oflabel to enter hypusine from labeled spermidine formed from [3-aminopropyl-3-3H]spermine (experiment 3) is that this spermidine is labeled at the terminal methylene position of its propylamine moiety only and that 3H in this position is not incorporated into hypusine during its biosynthesis. Indeed, there is evidence that the in vivo conversion of spermine to spermidine proceeds by way of direct oxidative cleavage of spermine to spermidine and 3-aminopropionaldehyde (11) . The suggestion that label from the butylamine portion of spermidine, but not that from the terminal methylene position of its propylamine part, enters hypusine is consistent with the evidence from the oxidation experiments that only the 4-amino-2-hydroxybutyl moiety of hypusine contains label derived from spermidine. Fig. 4 ). In cells from this donor, a weakly labeled low molecular weight protein with a more basic pI may be seen (B in Fig. 4 ), but this was only apparent after 10 days to 2 weeks of fluorographic exposure. In repeated studies with lymphocytes from different normal donors, two small labeled proteins with relatively basic pIs were sometimes seen, as was reported earlier (1). However, only protein A was labeled in preparations from all donors, and it was the predominant one in four of five donors. Whether this variability is a result of differences among normal donors or is due to technical effects is not known.
Careful comparison of the stained gel of Fig. 4 and the fluorogram prepared from this gel indicates that protein A can be detectable by Coomassie blue staining. Ifthis indeed is the case, protein A is not a minor species; the staining technique used detects only the more abundant proteins (12) .
To define the radioactive constituent of the most intensely labeled protein (A in Fig. 4) as hypusine, we excised the areas containing this labeled protein from gels prepared from two separate donors, directly hydrolyzed each in acid, and analyzed each for hypusine. A single peak of radioactivity that eluted at the exact time ofhypusine in the ion exchange chromatographic system of Fig. 1 was found in each case. Of the total trichloroacetic acid-precipitable radioactivity applied to the gels the fact that 35-40% was recovered from this labeled area ofthe gels is further evidence that this protein is the predominant hypu- sine-containing protein of lymphocytes. DISCUSSION The data presented here provide evidence that hypusine is a constituent amino acid of a small acidic protein of lymphocytes and that the 4-amino-2-hydroxybutyl moiety of this unusual amino acid derives in part from the butylamine portion of spermidine. In enzymic machinery required to catalyze the modification. The ultimate, but perhaps more difficult, goal will be the assignment ofa role in cellular function to the hypusine-containing protein.
We recently reported that small amounts of labeled putrescine and spermidine are bound covalently to protein through y-glutamylamide linkage in lymphocytes during growth with [3H]putrescine (1) . Whether our present failure to detect putrescine-and spermidine-containing proteins after two-dimensional gel electrophoresis is a consequence ofdistribution ofthe labeled amines in a number of proteins or is simply due to the relatively low amounts of labeled amines associated with one or a few proteins is not known. The amounts of radioactivity in the weakly labeled proteins observed after separation of some cell preparations were too small to allow identification of the labeled constituent.
There has been an accumulation of evidence for posttranslational modifications involving the --amino groups of lysine residues. Among these are production of E-methylated lysine residues (14-17) and formation of e-(y-glutamyl)lysine crosslinks (for review, see ref. 18) . In this regard, a suggestion of Imaoka and Nakajima (4) that hypusine is derived from protein-bound lysine by addition of a 4-amino-2-hydroxybutyl moiety at the lysine E-amino group seems attractive. However, definitive experimental evidence has not as yet been offered in support of this hypothesis.
The recognition of spermidine as the precursor of the 4-amino-2-hydroxybutyl radical for hypusine biosynthesis adds new considerations to polyamine metabolic transformations. This finding, together with our recent observations on the transglutaminase-catalyzed incorporation of putrescine and polyamines per se into proteins in biological systems (1) , reveals a structural contribution by these low molecular weight substances to biological macromolecules. Clues as to the catalytic mechanism by which spermidine contributes its butylamine moiety to the hydroxylated butylamine portion of hypusine do not appear to be contained in present knowledge of polyamine metabolism in mammals. Investigations of this transformation should, therefore, provide new insights into polyamine metabolic pathways.
